← Leaderboards
Nick J Willett
Georgia Institute Of Technology
$2,824,662
Attributed
$3,741,701
Total exposure
6
Grants
5
Lead (contact PI)
Attributed= this PI's even-split share of every grant they're on (the fair, additive number). Exposure = full size of all those grants.
Funding over time
peak $769.5K · FY2011–25$1M$750K$500K$250K$0
'11
'12
'13
'14
'15
'16
'17
'18
'19
'20
'21
'22
'23
'24
'25
Funding mix
By agency
NIH$3,741,701 · 4
VA$0 · 2
By mechanism
R01$3,127,313 · 2
R21$512,800 · 1
F32$101,588 · 1
I01$0 · 1
I21$0 · 1
Top collaborators
- Scott D. Boden4 shared
- Sreedhara Sangadala2 shared
Most similar at Georgia Institute Of Technology
Same institution · by research overlap
- Kara E McCloskey$432,828
- Johnna S Temenoff$7,791,981
- Casey E Vantucci$348,191
Others in their field
Top investigators on “Operative Surgical Procedures”
- Sonia M Thomas · Research Triangle Institute$701,865,642
- Tracy L Nolen · Research Triangle Institute$474,487,152
- Larry Arthur$195,389,208
- Norman Wolmark · Nsabp Foundation, Inc.$177,775,854
- Lawrence Corey · Fred Hutchinson Cancer Center$130,508,383
- Richard K. Wilson · Washington University$128,382,063
Research focus
Operative Surgical ProceduresHistologyEngineeringRegenerativeInjuryProductionScaffoldAnimalsMuscleAutologous TransplantationPre-Clinical ModelMuscle RegenerationFunctional OutcomesHealingRepairedMilitary PersonnelDefectTissuesGaitPublicationsAttenuatedImpairmentTissue EngineeringRattus
Grant awards (26)
Small Molecule Inhibition of Noggin to Induce Spinal Fusion$321,513
R01 · FY2025 · AR
Engineering the Immune and Fibrotic Response in Volumetric Muscle Loss$294,859
R01 · FY2025 · AR · contact PI
Engineering the Immune and Fibrotic Response in Volumetric Muscle Loss$89,294
R01 · FY2025 · AR · contact PI
Small Molecule Inhibition of Noggin to Induce Spinal Fusion$336,065
R01 · FY2024 · AR
Engineering the Immune and Fibrotic Response in Volumetric Muscle Loss$317,397
R01 · FY2024 · AR · contact PI
Engineering the Immune and Fibrotic Response in Volumetric Muscle Loss$89,294
R01 · FY2024 · AR · contact PI
Engineering the Immune and Fibrotic Response in Volumetric Muscle Loss$26,793
R01 · FY2024 · AR · contact PI
Combined Regenerative and Rehabilitation Therapies for Extremity Trauma$0
I01 · FY2024 · VA · contact PI
Small Molecule Inhibition of Noggin to Induce Spinal Fusion$330,840
R01 · FY2023 · AR
Engineering the Immune and Fibrotic Response in Volumetric Muscle Loss$327,346
R01 · FY2023 · AR · contact PI
Combined Regenerative and Rehabilitation Therapies for Extremity Trauma$0
I01 · FY2023 · VA · contact PI
Small Molecule Inhibition of Noggin to Induce Spinal Fusion$332,860
R01 · FY2022 · AR
Engineering the Immune and Fibrotic Response in Volumetric Muscle Loss$323,620
R01 · FY2022 · AR · contact PI
Combined Regenerative and Rehabilitation Therapies for Extremity Trauma$0
I01 · FY2022 · VA · contact PI
Combined Regenerative and Rehabilitation Therapies for Extremity Trauma$0
I01 · FY2022 · VA · contact PI
Engineering the Immune and Fibrotic Response in Volumetric Muscle Loss$337,432
R01 · FY2021 · AR · contact PI
Combined Regenerative and Rehabilitation Therapies for Extremity Trauma$0
I01 · FY2020 · VA · contact PI
Combined Regenerative and Rehabilitation Therapies for Extremity Trauma$0
I01 · FY2019 · VA · contact PI
Combined Stem Cell and Rehabilitation Therapies for Osteoarthritis$0
I21 · FY2019 · VA · contact PI
Combined Regenerative and Rehabilitation Therapies for Extremity Trauma$0
I01 · FY2019 · VA · contact PI
Application of a Repurposed FDA Approved Drug as a Local Osteogenic Agent$288,450
R21 · FY2018 · TR · contact PI
Combined Stem Cell and Rehabilitation Therapies for Osteoarthritis$0
I21 · FY2018 · VA · contact PI
Application of a Repurposed FDA Approved Drug as a Local Osteogenic Agent$224,350
R21 · FY2017 · TR · contact PI
Combined Stem Cell and Rehabilitation Therapies for Osteoarthritis$0
I21 · FY2017 · VA · contact PI
Limb Restoration Using a Novel Rat Model of Composite Bone and Muscle Injury$52,190
F32 · FY2012 · AR · contact PI
Limb Restoration Using a Novel Rat Model of Composite Bone and Muscle Injury$49,398
F32 · FY2011 · AR · contact PI